Shares of Eli Lilly & Co. (LLY) are soaring Tuesday morning on reports of its abemaciclib drug seeing success in a late-stage breast cancer study. The stock has gapped higher and is climbing on heavy volume. Let's check out the charts and indicators to see how much prices could rally.
More from Investing
These recently downgraded names are displaying both quantitative and technical deterioration.
Options on this retail name are liquid and provide a more-than-adequate return even if the stock does nothing over the term of the trade.
How you deal with each of these issues will determine your level of profits.
There are reasons why AMD and many chip equipment stocks closed higher on Friday, even as Intel's shares tumbled.